Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors

Viruses(2021)10.3390/v13081594Source: DataRank Database

COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors is a research paper published in Viruses (2021). On theSindex it has a DataRank of 0. It has been cited 44 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access44 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (60)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Massimo Franchini ORCID,Liise‐anne Pirofski,Thierry Burnouf ORCID,DeLisa Fairweather ORCID,Michael J. Joyner ORCID

Live enrichment

PubMed:34452459

National Institutes of Health

Grant: 1R21AI152318-01

Adipose-derived biogenic nanoparticles for treatment of myocarditis/DCM(MPDPI)

National Institutes of Health

Grant: 5R21AI154927-02

Sex differences in exercise-induced mitochondrial function during viral myocarditis

National Institutes of Health

Grant: 1R21AI145356-01

Role of viral mitophagosomes in driving sex differences in myocarditis

NIAID NIH HHS

Grant: R21 AI145356

NIAID NIH HHS

Grant: R21 AI152318

NIAID NIH HHS

Grant: R21 AI154927

American Heart Association-American Stroke Association

goldLicense: cc-by

publisherhttps://www.mdpi.com/1999-4915/13/8/1594/pdf?version=1629257025

publisherhttps://www.mdpi.com/1999-4915/13/8/1594/pdf

repositoryhttps://doaj.org/article/f6e5cf02b9564b8c8820ab6be3e142c7

repositoryhttps://dx.doi.org/10.3390/v13081594

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8402718

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciencesAnti-Inflammatory AgentsAntibodies, NeutralizingAntibodies, ViralAutoantibodiesBlood Coagulation Factor InhibitorsBlood Coagulation FactorsCOVID-19Cross ReactionsExtracellular VesiclesHumansImmunization, PassiveImmunologic FactorsImmunosuppressive AgentsSARS-CoV-2COVID-19 Serotherapy

MeSH Terms

Anti-Inflammatory AgentsAntibodies, NeutralizingAntibodies, ViralAutoantibodiesBlood Coagulation Factor InhibitorsBlood Coagulation FactorsCOVID-19Cross ReactionsExtracellular VesiclesHumansImmunization, PassiveImmunologic FactorsImmunosuppressive AgentsSARS-CoV-2COVID-19 Serotherapy

Keywords

MDA5Anti-Inflammatory AgentsReviewCross ReactionsAntibodies, ViralMicrobiologyExtracellular VesiclesHumansImmunologic FactorsCOVID-19 SerotherapyAutoantibodiesBlood Coagulation Factor InhibitorsSARS-CoV-2Immunization, PassiveCOVID-19antithrombin IIIADAMTS13Antibodies, NeutralizingQR1-502Blood Coagulation Factorsinterferonsconvalescent plasmaImmunosuppressive Agentscontrolled trialsdecoy receptorsheterologous immunitythrombosis

Sustainable Development Goals

SDG 3: 3. Good health